WASHINGTON, Sept. 20, 2017 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterlyearnings conference call for the third quarter 2017 on Thursday, October 19, 2017 beginning at 8:00 a.m. ET and lasting approximately 1 hour.
The call and an accompanying slide presentation
You can access the conference call by dialing 888-280-4443 within the U.S. or 719-325-4886 outside the U.S. a few minutes before 8:00 a.m. ET and notifying the operator that you are dialing in for Danaher's earnings conference call (access code 1825026). A replay of the conference call will be available shortly after the conclusion of the call until Thursday, October 26, 2017. You can access the replay dial-in information on the "Investors" section of Danaher's website under the subheading "Events & Presentations."
Danaher's earnings press release, the webcast slides and other related presentation materials will be posted to the "Investors" section of Danaher's website under the subheading "Financial Reports & Earnings" beginning at 6:00 a.m. ET on the date of the earnings call and will remain available following the call.
Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in some of the most demanding and attractive industries, including health care, environmental and industrial. With more than 20 operating companies, Danaher's globally diverse team of over 62,000 associates is united by a common culture and operating system, the Danaher Business System. For more information, please visit www.danaher.com.
View original content:http://www.prnewswire.com/news-releases/danaher-schedules-third-quarter-2017-earnings-conference-call-300522862.html
SOURCE Danaher Corporation
Subscribe to our Free Newsletters!
Cushing syndrome is a collection of symptoms caused due to excessive amount of cortisol in the body ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...
Intermittent fasting is a complete or partial abstinence from food and caloric drinks for a ...View All